[EN] AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDRS<br/>[FR] DERIVES AZETIDINECARBOXAMIDE ET LEUR UTILISATION POUR LE TRAITEMENT DE TROUBLES A MEDIATION DU RECEPTEUR DU CB1
申请人:VERNALIS RES LTD
公开号:WO2004096794A1
公开(公告)日:2004-11-11
Compounds of formula (I) and their use in therapy, particularly for the treatment of a disorder mediated by CB1 receptors, such as obesity, wherein: R1 is aryl or heteroaryl; R2 is alkyl, aryl or heteroaryl; R3 is alkyl, aryl, heteroaryl, NR9R10, OR 15, or NR 16C(O)R17; Y is C=O, C=S, SO2, or (CR7R8)p; m = 1 or 2; n = 1 or 2; and p=1,2,3 or 4, R7 to R17 being as defined in the specification; wherein if -Y-R3 is -C(O)NH(alkyl) then: R1 and/or R2 is selected from heteroary1; and/or m and/or n is 2; and/or R11 and/or R12 is lower alkyl, or a pharmaceutically acceptable salt or prodrug thereof.
化合物的化学式(I)及其在治疗中的应用,特别是用于治疗由CB1受体介导的疾病,如肥胖,其中:R1为芳基或杂环芳基;R2为烷基,芳基或杂环芳基;R3为烷基,芳基,杂环芳基,NR9R10,OR 15,或NR 16C(O)R17;Y为C=O,C=S,SO2,或(CR7R8)p;m = 1或2;n = 1或2;p=1,2,3或4,R7到R17如规范中定义;其中如果-Y-R3为-C(O)NH(烷基)则:R1和/或R2从杂芳基中选择;和/或m和/或n为2;和/或R11和/或R12为较低烷基,或其药用盐或前药。